TRMT11
tRNA (guanine(10)-N(2))-methyltransferase TRMT11
Also known as: C6orf75, dJ187J11.2, MDS024, TRM11, TRM11_HUMAN, TRMT11-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7Z4G4
- Gene
- TRMT11
- Ensembl
- ENSG00000066651
- Chromosome
- 6
- Canonical length
- 463 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nuclear bodies
OverviewNCBI Gene
Enables tRNA (guanine(10)-N2)-methyltransferase activity. Predicted to be involved in methylation and tRNA processing. Located in mitochondrion. Part of tRNA (m2G10) methyltransferase complex. Is active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
463 residues, UniProt reviewed canonical sequence.
>Q7Z4G4|TRMT11
1 MALSCTLNRY LLLMAQEHLE FRLPEIKSLL LLFGGQFASS QETYGKSPFW ILSIPSEDIA
61 RNLMKRTVCA KSIFELWGHG QSPEELYSSL KNYPVEKMVP FLHSDSTYKI KIHTFNKTLT
121 QEEKIKRIDA LEFLPFEGKV NLKKPQHVFS VLEDYGLDPN CIPENPHNIY FGRWIADGQR
181 ELIESYSVKK RHFIGNTSMD AGLSFIMANH GKVKENDIVF DPFVGTGGLL IACAHFGAYV
241 YGTDIDYNTV HGLGKATRKN QKWRGPDENI RANLRQYGLE KYYLDVLVSD ASKPSWRKGT
301 YFDAIITDPP YGIRESTRRT GSQKEIPKGI EKWEKCPESH VPVSLSYHLS DMFLDLLNFA
361 AETLVLGGRL VYWLPVYTPE YTEEMVPWHP CLELVSNCEQ KLSSHTSRRL ITMEKVKKFE
421 NRDQYSHLLS DHFLPYQGHN SFREKYFSGV TKRIAKEEKS TQELocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRMT11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 26 nTPM
Expression across tissuesHPA
Tissue
- liver: 26 nTPM
- cerebellum: 19 nTPM
- pituitary gland: 18 nTPM
- retina: 16 nTPM
- endometrium: 14 nTPM
- blood vessel: 14 nTPM
Single-cell type
- myonuclei: 357 nCPM
- choroid plexus epithelial cells: 354 nCPM
- thyrotrophs: 340 nCPM
- somatotrophs: 329 nCPM
- brain excitatory neurons: 301 nCPM
- brain inhibitory neurons: 299 nCPM
Immune cell
- MAIT T-cell: 11 nTPM
- naive CD4 T-cell: 9.5 nTPM
- naive CD8 T-cell: 8.6 nTPM
- memory CD4 T-cell: 7.9 nTPM
- NK-cell: 7.7 nTPM
- memory B-cell: 7.1 nTPM
Brain region
- cerebellum: 28 nTPM
- cerebral cortex: 21 nTPM
- white matter: 19 nTPM
- hypothalamus: 17 nTPM
- midbrain: 16 nTPM
- basal ganglia: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.12
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.02
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- methyltransferase activity
- tRNA binding
- tRNA (guanine(10)-N2)-methyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ribosomal RNA large subunit methyltransferase K/L-like, methyltransferase domain
- DNA methylase, N-6 adenine-specific, conserved site
- S-adenosyl-L-methionine-dependent methyltransferase superfamily
- RMKL-like, methyltransferase domain
- tRNA (guanine(10)-N(2))-methyltransferase TRMT11
- tRNA (guanine(10)-N(2))-methyltransferase TRMT11, N-terminal domain
- Tmrp11 THUMP N-terminal domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRMT11 as an antibody target. Whether an autoantibody or antibody against TRMT11 could matter depends on whether native TRMT11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRMT11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TRMT11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...